专利检索 ap:("CytomX Therapeutics, Inc.") AND inv:"NGUYEN, Margaret" 第 1 页

1.

发明公开
ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF 审中-公开
标题翻译：抗PDL1抗体，活化抗PDL1抗体及其使用方法

公开(公告)号：EP3268392A2

公开(公告)日：2018-01-17

申请号：EP16710662.4

申请日：2016-03-14

申请人： CytomX Therapeutics, Inc.

发明人： WEST, James William , MEI, Li , MOORE, Stephen James , NGUYEN, Margaret , HOSTETTER, Daniel , VASILJEVA, Olga , SAGERT, Jason , TERRETT, Jonathan

IPC分类号： C07K16/28 , A61K49/00 , G01N33/53

CPC分类号： C07K16/2827 , A61K39/3955 , A61K49/0021 , A61K49/0041 , A61K49/0058 , A61K2039/505 , C07K2317/21 , C07K2317/33 , C07K2317/34 , C07K2317/55 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/622 , C07K2317/70 , C07K2317/73 , C07K2317/76 , C07K2317/92

摘要： The invention relates generally to antibodies that bind programmed death ligand 1 (PDL1), activatable antibodies that specifically bind to PDL1 and methods of making and using these anti-PDL1 antibodies and anti-PDL1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.